Researchers at Stanford University have developed a novel imaging technique that identifies brain tumors missed by conventional MRI scans. The enhanced contrast MRI method detected previously undetectable tumors in 23% of patients who had normal standard MRI results, according to findings published in Science Translational Medicine.
The breakthrough technology combines advanced gadolinium-based contrast agents with sophisticated signal processing algorithms, enabling detection of tumors as small as 2 millimeters compared to the 5-millimeter threshold of standard MRI. In a prospective study of 284 patients with suspected brain tumors, enhanced contrast MRI achieved an 89% detection rate versus 72% for conventional imaging.
The innovation holds particular promise for early detection of glioblastoma, the most aggressive form of brain cancer. Clinical validation trials are planned for 2027 across multiple medical centers to establish the technique’s clinical utility and potential to improve patient outcomes.
Read the full article on GMJ Newsroom.
Was this article helpful?
